Household Healthcare Sector

Sharps Technology

Market Cap: US$3.9m

A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

ALR Technologies SG

Market Cap: US$3.9m

A data management company, provides diabetes care management solutions for human and animal health diabetes.

Matinas BioPharma Holdings

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

Zelira Therapeutics

Market Cap: AU$5.9m

A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States.

Totally

Market Cap: UK£2.8m

Provides healthcare services in the United Kingdom and Ireland.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

Applied DNA Sciences

Market Cap: US$3.8m

A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

PainReform

Market Cap: US$3.8m

A clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.

Conduit Pharmaceuticals

Market Cap: US$3.8m

A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.

InhaleRx

Market Cap: AU$5.8m

A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.

Sonnet BioTherapeutics Holdings

Market Cap: US$3.7m

A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.

Avricore Health

Market Cap: CA$5.1m

Engages in the health data and point-of-care technologies business.

CannaPharmaRX

Market Cap: US$3.6m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

Lixte Biotechnology Holdings

Market Cap: US$3.6m

A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Tharimmune

Market Cap: US$3.6m

A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

Aion Therapeutic

Market Cap: CA$5.0m

Engages in the health and wellness business in the United States.

GlucoTrack

Market Cap: US$3.6m

A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.

VivoSim Labs

Market Cap: US$3.6m

A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

Innovative Holdings Alliance

Market Cap: US$3.6m

A medical technology holding company, offers personal care products in North America.

Mystic Holdings

Market Cap: US$3.5m

Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.

Ayurcann Holdings

Market Cap: CA$4.9m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Leveljump Healthcare

Market Cap: CA$4.8m

Provides radiology services.

Genetic Technologies

Market Cap: AU$5.7m

A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

AquaBounty Technologies

Market Cap: US$3.5m

Operates as a land-based aquaculture company in the United States.

60 Degrees Pharmaceuticals

Market Cap: US$3.5m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

Roquefort Therapeutics

Market Cap: UK£2.6m

A material biotech company, engages in the development of medicines for the treatment of cancer.

BSF Enterprise

Market Cap: UK£2.5m

Develops and commercializes cutting-edge tissue-engineered solutions.

Premier Health of America

Market Cap: CA$4.7m

Engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada.

Adherium

Market Cap: AU$5.3m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

Enzolytics

Market Cap: US$3.4m

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

CTT Pharmaceutical Holdings

Market Cap: US$3.4m

Engages in the development of oral drug delivery systems for pain management and treatment.

Palisade Bio

Market Cap: US$3.3m

A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.

ProtoKinetix

Market Cap: US$3.3m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Bionoid Pharma

Market Cap: US$3.3m

Engages in the hemp cultivation business.